{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:42:12Z","timestamp":1788478932544,"version":"build-2803163510"},"reference-count":46,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Clinical Toxicology"],"published-print":{"date-parts":[[2025,1,2]]},"DOI":"10.1080\/15563650.2024.2430311","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T07:49:03Z","timestamp":1733384943000},"page":"23-31","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Advancing toxicovigilance of recreational drugs, including new psychoactive substances, by using data from four European poison centres"],"prefix":"10.1080","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5296-197X","authenticated-orcid":false,"given":"Aza","family":"Kader","sequence":"first","affiliation":[{"name":"Swedish Poisons Information Centre","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9803-7324","authenticated-orcid":false,"given":"Maren","family":"Hermanns-Clausen","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Adolescent Medicine and Neonatology, Faculty of Medicine, Poisons Information Center, Center for Pediatrics, University of Freiburg","place":["Freiburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2746-1371","authenticated-orcid":false,"given":"Antoinette","family":"van Riel","sequence":"additional","affiliation":[{"name":"Dutch Poisons Information Centre, University Medical Center Utrecht, Utrecht University","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7172-0676","authenticated-orcid":false,"given":"Katrin","family":"Faber","sequence":"additional","affiliation":[{"name":"Tox Info Suisse, National Poisons Information Centre, Associated Institute of the University of Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9823-008X","authenticated-orcid":false,"given":"Laura","family":"Hondebrink","sequence":"additional","affiliation":[{"name":"Dutch Poisons Information Centre, University Medical Center Utrecht, Utrecht University","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"e_1_3_4_2_1","unstructured":"United Nations Office on Drugs and Crime (UNODC). World drug report 2023. Vienna: United Nations Office on Drugs and Crime; 2023. Available from: https:\/\/www.unodc.org\/res\/WDR-2023\/WDR23_Exsum_fin_DP.pdf"},{"key":"e_1_3_4_3_1","unstructured":"European Union Drugs Agency (EUDA). New psychoactive substances \u2013 the current situation in Europe (European Drug Report 2023). Brussels: European Union Drugs Agency; 2023 [cited 2024 Jul 25]. Available from: https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2023\/new-psychoactive-substances_en"},{"key":"e_1_3_4_4_1","unstructured":"European Union Drugs Agency (EUDA). European drug report 2022: trends and developments. Brussels: European Union Drugs Agency; 2022 [cited 2024 Jul 25]. Available from: https:\/\/www.euda.europa.eu\/publications\/edr\/trends-developments\/2022_en"},{"key":"e_1_3_4_5_1","unstructured":"New psychoactive substances (NPS). Brussels: European Union Drugs Agency; 2023 [cited 2024 Jul 25]. Available from: https:\/\/www.euda.europa.eu\/topics\/nps_en"},{"key":"e_1_3_4_6_1","unstructured":"UNODC early warning advisory on new psychoactive substances. Vienna: United Nations Office on Drugs and Crime; 2023 [cited 2024 Jul 25]. Available from: https:\/\/www.unodc.org\/LSS\/Page\/NPS"},{"key":"e_1_3_4_7_1","unstructured":"United Nations Office on Drugs and Crime (UNODC). The challenges of new psychoactive substances. Vienna: United Nations Office on Drugs and Crime; 2013 [cited 2024 Jul 21]. Available from: https:\/\/www.unodc.org\/documents\/scientific\/NPS_Report.pdf"},{"key":"e_1_3_4_8_1","unstructured":"European Union Drugs Agency (EUDA). European drug report 2023: trends and developments. Brussels: European Union Drugs Agency; 2023 [cited 2024 Jul 25]. Available from: https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2023_en"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2022.2137524"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2020.1806296"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2022.2042011"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2020.1861287"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2018.1510502"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/01480545.2020.1868494"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14281"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109244"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0b013e31826c9a97"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/pec.0b013e3182808ae2"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.05.048"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2023.2215402"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2022.04.022"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2022.04.022"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2022.2113094"},{"key":"e_1_3_4_24_1","unstructured":"Statista. Hamburg: Statista; 2024 [cited 2024 Jul 25]. Available from: https:\/\/www.statista.com\/"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2023.2268981"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12185970"},{"key":"e_1_3_4_27_1","first-page":"45","volume-title":"The Netherlands and synthetic drugs, an inconvenient truth","author":"Tops P","year":"2018","unstructured":"Tops P, van Valkenhoef J, van der Torre E, et\u00a0al. The Netherlands and synthetic drugs, an inconvenient truth. The Hague: Eleven International Publishing; 2018. p. 45."},{"key":"e_1_3_4_28_1","unstructured":"Verhej A. The paradox of Dutch drug culture. SVJ Media; 2021 [cited 2024 Jul 16]. Available from: https:\/\/svjmedia.nl\/internationaljournalism\/2506\/the-paradox-of-the-dutch-drugs-culture\/"},{"key":"e_1_3_4_29_1","unstructured":"European Union Drugs Agency (EUDA). European drug report 2020: trends and developments. Brussels: European Union Drugs Agency; 2020 [cited 2024 Jul 25]. Available from: https:\/\/www.euda.europa.eu\/publications\/edr\/trends-developments\/2020_en"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.06.011"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2021.111148"},{"key":"e_1_3_4_32_1","unstructured":"European Drug Emergencies Network (Euro-den plus): data and analysis. Brussels: European Union Drugs Agency; 2024 [cited 2024 Jul 25]. Available from: https:\/\/www.euda.europa.eu\/publications\/data-factsheet\/european-drug-emergencies-network-euro-den-plus-data-and-analysis_en"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110144"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2022.2095282"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2017.1400067"},{"key":"e_1_3_4_36_1","unstructured":"Trend reports. NPS discovery. Horsham (PA): CFSRE; 2024 [cited 2024 Jul 16]. Available from: https:\/\/www.cfsre.org\/nps-discovery\/trend-reports"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(24)00001-X"},{"key":"e_1_3_4_38_1","unstructured":"Duff JH Shen WW Rosen LV et\u00a0al. The opioid crisis in the United States \u2013 a brief history (Congressional Research Service Report IF12260 version 3). Washington (DC): Library of Congress; 2022. Available from: https:\/\/crsreports.congress.gov\/product\/pdf\/IF\/IF12260"},{"key":"e_1_3_4_39_1","unstructured":"European Union Drugs Agency (EUDA). European drug report: 2023 drug-induced deaths. Brussels: European Union Drugs Agency; 2023 [cited 2024 Jul 16]. Available from: https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2023\/drug-induced-deaths_en"},{"key":"e_1_3_4_40_1","unstructured":"Nugteren-van Lonkhuyzen JJ Visser C Mulder-Spijkerboer HN et\u00a0al. The Dutch Poison Information Center annual report 2023. Utrecht: University Medical Center Utrecht; 2024. Available from: https:\/\/assets-eu-01.kc-usercontent.com\/4ecb7ebb-946a-0154-473e-737dbc98bace\/e7995e4f-cefc-42f7-8e26-4b37348986d0\/NVIC_jaaroverzicht_2023_definitief_openbaar_final.pdf"},{"key":"e_1_3_4_41_1","unstructured":"Van Laar MW van Beek RJJ Beenakkers EMT et\u00a0al. Nationale Drug Monitor 2021. Utrecht; The Hague: Trimbos-instituut\/WODC; 2022. Available from: https:\/\/repository.wodc.nl\/bitstream\/handle\/20.500.12832\/3165\/3247-nationale-drug-monitor-2021.pdf?sequence=1&isAllowed=y"},{"key":"e_1_3_4_42_1","unstructured":"NPS 8.0 Laatste feiten en trends. Nationale Drug Monitor. Utrecht; The Hague: Trimbos-instituut\/WODC; 2024 [2024 Jul 16] Available from: https:\/\/www.nationaledrugmonitor.nl\/nps-laatste-feiten-en-trends\/"},{"issue":"4","key":"e_1_3_4_43_1","first-page":"357","article-title":"Do users of new psychoactive substances take what they think they take? An overview of drug product contents analysed within the Swedish STRIDA project","volume":"53","author":"B\u00e4ckberg M","year":"2015","unstructured":"B\u00e4ckberg M, Lindeman E, Beck O, et\u00a0al. Do users of new psychoactive substances take what they think they take? An overview of drug product contents analysed within the Swedish STRIDA project. Clin Toxicol. 2015;53(4):357\u2013358.","journal-title":"Clin Toxicol"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2024.05.010"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.648273"},{"key":"e_1_3_4_46_1","unstructured":"EU drug markets \u2013 impact of COVID-19. Brussels: European Union Drugs Agency; 2020 [cited 2024 Jul 25]. Available from: https:\/\/www.euda.europa.eu\/publications\/joint-publications\/eu-drug-markets-impact-of-covid-19_en"},{"key":"e_1_3_4_47_1","unstructured":"Impact of COVID-19 on drug markets use harms and drug services in the community and prisons. Brussels: European Union Drugs Agency; 2021 [cited 2024 Jul 25]. Available from: https:\/\/www.euda.europa.eu\/publications\/ad-hoc-publication\/impact-covid-19-drug-markets-use-harms-and-drug-services-community-and-prisons_en"}],"container-title":["Clinical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15563650.2024.2430311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T19:56:32Z","timestamp":1770926192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15563650.2024.2430311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,2]]}},"alternative-id":["10.1080\/15563650.2024.2430311"],"URL":"https:\/\/doi.org\/10.1080\/15563650.2024.2430311","relation":{},"ISSN":["1556-3650","1556-9519"],"issn-type":[{"value":"1556-3650","type":"print"},{"value":"1556-9519","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-08-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}